| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Dec 1, 2018Virtual Press Office and PR Newswire: General Trade show news
RogCon Biosciences (RogCon), a biotechnology company focused on discovering and developing novel therapeutics for children suffering from SCN2A mutations, today announced preclinical data in a...
-
Dec 1, 2018Virtual Press Office and PR Newswire: General Trade show news
100% overall and 80% complete response rate in 10 patients with relapsed or refractory follicular lymphoma treated with 5 mg or more of REGN1979 Plan to initiate in 2019 a potentially...
-
Dec 1, 2018Virtual Press Office and PR Newswire: General Trade show news
MEI Pharma, Inc. (NASDAQ: MEIP), a late-stage pharmaceutical company focused on advancing new therapies for cancer, today announced preclinical data presented at the 2018 American Society of...
-
Dec 1, 2018Virtual Press Office and PR Newswire: General Trade show news
Tolero Pharmaceuticals, Inc., a clinical-stage company focused on developing novel therapeutics for hematological and oncological diseases, today presented new data from the ongoing Phase 2 Zella...
-
Dec 1, 2018Virtual Press Office and PR Newswire: General Trade show news
New data from a post hoc analysis of the Phase II SUSTAIN study of crizanlizumab -- a once-a-month, humanized anti-P-selectin monoclonal antibody infusion being investigated for the treatment of...
